Altimmune, Inc. (ALT)

3.865 -0.12 (-2.89%) USD  |  NASDAQ  |  Dec 26, 15:56
More

Altimmune Proceeds from Stock Option Exercised (Quarterly)

Proceeds from Stock Option Exercised (Quarterly) Chart

View Proceeds from Stock Option Exercised (Quarterly) for ALT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Proceeds from Stock Option Exercised (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Proceeds from Stock Option Exercised (Quarterly) Range, Past 5 Years

View Proceeds from Stock Option Exercised (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Proceeds from Stock Option Exercised (Quarterly) Benchmarks

View Proceeds from Stock Option Exercised (Quarterly) Benchmarks
Start Trial
Viking Therapeutics, Inc. Upgrade
Amgen, Inc. Upgrade
Rhythm Pharmaceuticals, Inc. Upgrade
Terns Pharmaceuticals, Inc. Upgrade
X4 Pharmaceuticals, Inc. Upgrade